Algry Quimica 2002 Results: Better than Ever

Madrid (Spain), 16.01.2003 --Algry Quimica, the leading European company for the manufacture of choline derivatives for nutraceutical, food and pharmaceutical uses, announced today that the sales of its choline derivatives increased 65% during the year 2002, over 2001 results.

This increase has been based on its policy of expanding its US market increasing exports of its products to nutritional and nutraceutical companies worldwide, specially to Europe and North and South America. Algry is now active in more than 25 countries.

The European group also announced further invesments at its choline salts facility at Huelva, to boost manufacturing capabilities in choline salts in order to meet customers' increasing demand and the growing consumption trends in choline-based products.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.